Skip to main content
Caplight Logo









BioFeyn

BioFeyn

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://biofeyn.com

Last Round

Accelerator

Oct 21, 2021

Total Funding Raised

$409,000

Company Overview

BioFeyn operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was an Accelerator round in October 2021.

BioFeyn is a life sciences company that develops nanocapsule-based delivery mechanisms for nutrients, medicines, and vaccines to improve efficiency and sustainability in aquaculture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Circular Economy, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

BioFeyn Comparables

Compare BioFeyn with similar companies based on industry and business-model similarity.

BioFeyn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LifeBioencapsulation
79%
FeedVax
78%
IctioBiotic
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

BioFeyn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 21, 2021
AcceleratorOct 30, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

BioFeyn Investors

Notable investors and investment history

BioFeyn investors
InvestorRounds
IndieBioAccelerator
Katapult OceanAccelerator
AgFunderAccelerator
SOSVAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 21, 2021

    $150K round led by Katapult Ocean

  • Oct 30, 2020

    $250K round led by IndieBio.

Book a demo to see all signals

For institutional investors. Book with your work email.

BioFeyn Filings

Explore SEC and related filing metadata, where available.

BioFeyn filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about BioFeyn's valuation, stock price, and market status.

Is BioFeyn a public or private company?

BioFeyn is a private company.

What is the current stock price of BioFeyn?

BioFeyn is a private company, so its shares have no public market price. Caplight tracks BioFeyn's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BioFeyn worth (valuation)?

Valuation information for BioFeyn is not publicly available.

Can I buy BioFeyn stock?

BioFeyn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BioFeyn's last funding round?

BioFeyn's most recent funding round was Accelerator on October 21, 2021.

Who are the main investors in BioFeyn?

Key investors in BioFeyn include IndieBio, Katapult Ocean.

Will BioFeyn IPO soon?

No public IPO plans have been announced for BioFeyn.

How can I track BioFeyn secondary market activity?

Caplight tracks bids, offers, and trades in BioFeyn's shares on secondary markets.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range1
Year Founded2019
Last FundingOct 21, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?